Mesh Bio is a digital health start up that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. We translate clinical data and numbers into actionable insights that help patients better manage their health, lifestyle and disease risks.
Co-Founder & CTO
Arsen Batagov was a former researcher in Russia, where he launched the Gene Diagnostics facility in the Russian Research Institute of Cardiology in 2003. In 2009, Arsen moved to Singapore and joined A*STAR, to focus on a broad range of bioinformatics and systems biology of cancers. He then served as the Bioinformatics Director in Vishuo Biomedical Ltd, Singapore before he co-founded Mesh Bio.
Arsen obtained his BSc and MSc in Genetics from St Petersburg Medical University, and pursued a PhD in Biochemical Engineering at University College London.
Andrew Wu, PhD
Co-Founder & CEO
Dr Andrew Wu was previously Chief Operating Officer of Clearbridge Biomedics (now known as Biolidics) where he developed innovative cancer diagnostics technology in the field of liquid biopsy. He was also Chief Product Officer of Clearbridge Health. Both companies are now listed on SGX Catalist. Prior to Clearbridge, Andrew was Technical Director for CordLife, managing the laboratory operations and clinical affairs for the group.
Andrew holds a Bachelors and PhD in Biochemical Engineering from University College London.
Melvin Heng, MBBS MBA
Co-Founder & Medical Advisor
Dr Melvin Heng is the Co-Founder of Mesh Bio and currently the Chief Operating Officer at Gleneagles Hospital Singapore, part of the IHH Healthcare group. He was previously Director and Chief Information Officer of the Onecare Medical, a group of primary care clinics across Singapore. He is passionate about using digital technologies for healthcare delivery.
Melvin obtained his MBBS from St George’s Hospital in London, UK and a MBA in International Health from Frankfurt School of Finance & Management.
Wen Bin Lai, PhD MBA
Head of Partnerships
Dr Lai Wen Bin has more than 20 years’ operational experience in biopharmaceutical startups, healthcare and academic institutions, such as National University Health System and Clearbridge Biomedical Sciences Accelerator.
Wen Bin obtained her Ph.D. from the University of Cambridge and a First Class Honours in B. Eng (Chemical) from the National University of Singapore. She later received her MBA from the Singapore Management University, where she graduated as valedictorian.
Healthcare Solutions Manager
Stacy comes from a Life Sciences background with experience in Pharmaceutical and Medical devices product management and sales. When she is not formulating solutions for clients, she likes to chill with her cats or cycle around the world.
Senior Software Engineer
Zhongyi holds a Bachelor’s degree in Computational Biology and a Master’s degree in Computer Science. He was previously in the robotics industry and is strongly passionate about new technology.
Junior Software Developer
Justin is passionate about solving problems, learning and designing solutions that add value to users. He also enjoys rock climbing when he isn’t coding.